Cargando…

Concerns about renal safety of HES 130

Detalles Bibliográficos
Autores principales:	Wiedermann, Christian J, Joannidis, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4057468/ https://www.ncbi.nlm.nih.gov/pubmed/23906024 http://dx.doi.org/10.1186/cc12805

Ejemplares similares

Is the literature inconclusive about the harm from HES? No
por: Wiedermann, Christian J., et al.
Publicado: (2016)

Correction to: Is the literature inconclusive about the harm from HES? No
por: Wiedermann, Christian J., et al.
Publicado: (2020)

Does volume substitution with HES 130/0.4 affect renal safety in abdominal aortic surgery?
por: Godet, G, et al.
Publicado: (2006)

HES 130/0.4, a new HES specification: tissue storage after multiple infusions in rats
por: Bepperling, F, et al.
Publicado: (1999)

Comparison of 6% HES 130/0.4 in a balanced electrolyte solution versus 6% HES 130/0.4 in saline solution in cardiac surgery
por: Base, E, et al.
Publicado: (2006)

Efficacy and safety of 10% HES 130/0.4 versus 10% HES 200/0.5 for plasma volume expansion in cardiac surgery patients
por: Ertmer, C, et al.
Publicado: (2011)

HES 130/0.4, a new HES specification: pharmacokinetics after multiple infusions of 10% solutions in healthy volunteers
por: Bepperling, F, et al.
Publicado: (1999)

Evaluation of effectiveness and safety of hydroxyethyl starch (HES 130 kDa/0.4) in burn resuscitation
por: Mokline, A, et al.
Publicado: (2012)

CRYSTMAS study adds to concerns about renal safety and increased mortality in sepsis patients
por: Hartog, Christiane S, et al.
Publicado: (2012)

Debate on HES safety is important, but must be based on facts
por: Haase, Nicolai, et al.
Publicado: (2013)

Hydroxyethyl starch HES 130/0.4 in paediatric surgery: results of an explorative, controlled, multicentre safety study
por: Lochbühler, H, et al.
Publicado: (2003)

Balanced Hydroxyethylstarch (HES 130/0.4) Impairs Kidney Function In-Vivo without Inflammation
por: Schick, Martin Alexander, et al.
Publicado: (2015)

Volume substitution therapy with HES 130/0.4 (Voluven(®)) versus HES 450/0.7 (hetastarch) during major orthopedic surgery
por: Gandhi, S, et al.
Publicado: (2005)

HES 130/0.4 impairs haemostasis and stimulates pro-inflammatory blood platelet function
por: Sossdorf, Maik, et al.
Publicado: (2009)

In vivo effect of hydroxyethyl starch solution (HES 130/0.4) on different fibrinogen assays
por: Schött, U, et al.
Publicado: (2014)

Prospective observational study for perioperative volume replacement with 6% HES 130/0,42, 4% gelatin and 6% HES 200/0,5 in cardiac surgery
por: Winterhalter, M, et al.
Publicado: (2010)

Large-dose hydroxyethyl starch (HES) 130/0.4 in elective coronary artery bypass surgery
por: Kasper, SM, et al.
Publicado: (2002)

A word of caution on renal risks of prothrombin complex concentrate use in cardiac surgery
por: Wiedermann, Christian J.
Publicado: (2016)

Causal relationship between hypoalbuminemia and acute kidney injury
por: Wiedermann, Christian J, et al.
Publicado: (2017)

Hypoalbuminemia and acute kidney injury: a meta-analysis of observational clinical studies
por: Wiedermann, Christian J., et al.
Publicado: (2010)

Correction to: Hypoalbuminemia and acute kidney injury: a meta-analysis of observational clinical studies
por: Wiedermann, Christian J., et al.
Publicado: (2020)

HES 130 kD, but not crystalloid volume support reduces leukocyte–endothelial cell interaction during endotoxemia
por: Hoffmann, JN, et al.
Publicado: (2002)

Accumulation of hydroxyethyl starch in human and animal tissues: a systematic review
por: Wiedermann, Christian J., et al.
Publicado: (2013)

Nephroprotective Potential of Human Albumin Infusion: A Narrative Review
por: Wiedermann, Christian J., et al.
Publicado: (2015)

The Boldt scandal still in need of action: the example of colloids 10 years after initial suspicion of fraud
por: Wiedermann, Christian J., et al.
Publicado: (2018)

Correction to: Accumulation of hydroxyethyl starch in human and animal tissues: a systematic review
por: Wiedermann, Christian J., et al.
Publicado: (2020)

Correction to: The Boldt scandal still in need of action: the example of colloids 10 years after initial suspicion of fraud
por: Wiedermann, Christian J., et al.
Publicado: (2020)

Human albumin and 6% hydroxyethyl starches (130/0.4) in cardiac surgery: a meta-analysis revisited
por: Wiedermann, Christian J.
Publicado: (2022)

Comparison of hydroxyethylstarch (HES 130/0.4) and 5% human albumin for volume substitution in pediatric neurosurgery: A retrospective, single center study
por: Schick, Martin A., et al.
Publicado: (2021)

He’s Come!!
por: Stewart, A. T.
Publicado: (1869)

Low-quality Trials as a Source of Heterogeneity in the Association of Hydroxyethyl Starch 130/0.4 or 0.42 with Excess Mortality in Sepsis
por: Wiedermann, Christian J
Publicado: (2016)

Adverse effects of hydroxyethyl starch (HES 130/0.4) on intestinal barrier integrity and metabolic function are abrogated by supplementation with Albumin
por: Wong, Yuk Lung, et al.
Publicado: (2016)

The effect of HES130/0.4 sodium chloride solution on kidney function following early fluid resuscitation in shock patients
por: Jiang, Haiyan, et al.
Publicado: (2021)

Einsatz von Albumin: State of the art
por: Mayerhöfer, Timo, et al.
Publicado: (2021)

Changes in the degree of substitution of HES in vivo and their influence on methods for determining HES concentrations in plasma
por: Lukasewitz, Peter, et al.
Publicado: (2023)

Concerns about the interpretation of subgroup analysis
por: Albuquerque, Arthur M., et al.
Publicado: (2022)

TLE4 acts as a corepressor of Hes1 to inhibit inflammatory responses in macrophages
por: Zhang, Xiang, et al.
Publicado: (2018)

Assessment of Hydroxyethyl Starch (6% HES 130/0.4) Kidney Storage in Critically Ill Dogs: A Post-mortem Prospective Study
por: Adamik, Katja-Nicole, et al.
Publicado: (2022)

Concerns about the ‘corporate capture’ of The Academy article
por: Butler, J Lauren, et al.
Publicado: (2023)

Concerns about subgroup analyses and reason for stopping remdesivir trial
por: Vijayaraghavan, Bharath Kumar Tirupakuzhi
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_98glrdkvc5o61u7bnk466ifnt6